dazmegrel has been researched along with Coronary Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apprill, P; Ashton, J; Buja, LM; Campbell, WB; Raheja, S; Schmitz, JM; Tilton, G; Willerson, JT | 1 |
| Borowski, A; de Vivie, ER; Hellige, G; Hoeft, A; Korb, H | 1 |
| Farber, NE; Gross, GJ; Pieper, GM | 1 |
| Hellige, G; Hoeft, A; Korb, H; Wober, W; Wolpers, HG | 1 |
| Böck, J; Hellige, G; Hoeft, A; Korb, H; Wober, W; Wolpers, HG | 1 |
| Parratt, JR; Wainwright, CL | 1 |
| Bullock, GR; Leprán, I; Parratt, JR; Szekeres, L; Wainwright, CL | 1 |
7 other study(ies) available for dazmegrel and Coronary Disease
| Article | Year |
|---|---|
Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic alpha-Antagonists; Animals; Arteriosclerosis; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Imidazoles; Male; Platelet Activating Factor; Platelet Aggregation; Serotonin Antagonists; Thromboxane B2 | 1985 |
Interference with the prostaglandin system as a therapeutical concept to protect the myocardium during ischemic stress: experimental studies with inhibition of thromboxane synthesis.
Topics: Animals; Coronary Disease; Dogs; Energy Metabolism; Hemodynamics; Imidazoles; Myocardium; Oxygen Consumption; Prostaglandin Antagonists; Thromboxane-A Synthase | 1988 |
Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
Topics: Animals; Coronary Circulation; Coronary Disease; Dogs; Energy Metabolism; Female; Heart; Hemodynamics; Imidazoles; Male; Myocardial Contraction; Phenylacetates; Phosphates; Prostaglandins; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase | 1988 |
Inhibition of thromboxane synthetase by the imidazole derivative 3-(1H-imidazol-1-yl-methyl)-2-methyl-1H-indole-1-propanoic acid as a novel therapeutic approach to experimental myocardial ischemia.
Topics: Animals; Coronary Disease; Dogs; Energy Metabolism; Heart; Hemodynamics; Imidazoles; Myocardium; Oxygen Consumption; Thromboxane-A Synthase | 1986 |
Preservation of myocardium in transient ischemia by the thromboxane synthetase inhibitor UK 38.485.
Topics: Animals; Coronary Circulation; Coronary Disease; Dogs; Energy Metabolism; Hemodynamics; Imidazoles; Myocardium; Oxygen Consumption; Thromboxane A2; Thromboxane-A Synthase | 1986 |
The effect of beta-adrenoceptor blockade and of thromboxane synthetase inhibition, alone and in combination, on arrhythmias resulting from myocardial ischemia.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Heart Rate; Heart Ventricles; Imidazoles; Male; Metoprolol; Oxidoreductases; Rats; Rats, Inbred Strains; Thromboxane-A Synthase | 1985 |
Effects of a combination of metoprolol and dazmegrel on myocardial infarct size in rats.
Topics: Animals; Coronary Disease; Drug Therapy, Combination; Imidazoles; Male; Metoprolol; Myocardial Infarction; Rats; Rats, Inbred Strains; Thromboxane-A Synthase; Time Factors | 1985 |